Publications by authors named "Ruediger Spitz"

Claim this Profile
C
Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastoma.
Jessica Theissen, Andre Oberthuer, Anja Hombach, Ruth Volland, Falk Hertwig, Ruediger Spitz

Genes Chromosomes Cancer· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of the MYCN oncogene in neuroblastoma.
Jessica Theissen, Marc Boensch, Ruediger Spitz, David Betts, Sabine Stegmaier

Clin Cancer Res· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97.
Barbara Hero, Thorsten Simon, Ruediger Spitz, Karen Ernestus, Astrid K Gnekow

J Clin Oncol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome.
Ruediger Spitz, Andre Oberthuer, Marc Zapatka, Benedikt Brors, Barbara Hero

Genes Chromosomes Cancer· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
Ruediger Spitz, Barbara Hero, Thorsten Simon, Frank Berthold

Clin Cancer Res· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma.
Ruediger Spitz, David R Betts, Thorsten Simon, Marc Boensch, Joern Oestreich

Cancer Genet Cytogenet· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative real-time PCR for quick simultaneous determination of therapy-stratifying markers MYCN amplification, deletion 1p and 11q.
Marc Boensch, André Oberthuer, Matthias Fischer, Matthias Skowron, Joern Oestreich, Ruediger Spitz

Diagn Mol Pathol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification.
Ruediger Spitz, B Hero, M Skowron, K Ernestus, F Berthold

Eur J Cancer· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.
Ruediger Spitz, Barbara Hero, Karen Ernestus, Frank Berthold

Clin Cancer Res· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.
Ruediger Spitz, Barbara Hero, Karen Ernestus, Frank Berthold

Med Pediatr Oncol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
Ruediger Spitz, Barbara Hero, Karen Ernestus, Frank Berthold

Clin Cancer Res· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.
Ruediger Spitz, Barbara Hero, Frank Westermann, Karen Ernestus, Manfred Schwab

Genes Chromosomes Cancer· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis